J. Chollet

Quality of life in SSc-ILD patients: Understanding the impact of the ILD and the needs of the SSc-ILD patients and their need for caregivers in France

G. de Pouvourville, E. Hachulla, Y. Allanore, 2021, Journal of scleroderma and related disorders.

Functional impairment in patients with major depressive disorder: the 2-year PERFORM study

J. Haro, B. Rive, B. Jönsson, 2018, Neuropsychiatric disease and treatment.

Epidemiology, Mortality and Healthcare Resource Utilization Associated With Systemic Sclerosis-Associated Interstitial Lung Disease in France

D. Maucort-Boulch, L. Boussel, S. Larrieu, 2021, Frontiers in Medicine.

Antidepressant switching patterns in the treatment of major depressive disorder: a General Practice Research Database (GPRD) Study

D. Saragoussi, D. Milea, Y. Chalem, 2012, International journal of clinical practice.

Pattern and predictors of sick leave among users of antidepressants: a Danish retrospective register-based cohort study.

L. Petersen, C. Gasse, D. Saragoussi, 2013, Journal of affective disorders.

Pharmacotherapeutic strategies for patients treated for depression in UK primary care: a database analysis

B. Rive, E. Clay, D. Saragoussi, 2015, Current medical research and opinion.

A clinical research practice datalink analysis of antidepressant treatment patterns and health care costs in generalized anxiety disorder.

E. Clay, D. Saragoussi, C. François, 2013, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Practice Datalink Analysis of Antidepressant Treatment Patterns and Health Care Costs in Generalized Anxiety Disorder

E. Clay, D. Saragoussi, C. François, 2013 .

Functional impairment in patients with major depressive disorder: the 2-year PerFOrM study

J. Haro, B. Rive, D. Saragoussi, 2018 .

Public Health Impact and Cost-Effectiveness of Empagliflozin (JARDIANCE®) in the Treatment of Patients with Heart Failure with Preserved Ejection Fraction in France, Based on the EMPEROR-Preserved Clinical Trial

L. Fauchier, N. Lamblin, P. Levy, 2023, PharmacoEconomics - open.